Plus, news about Telix Pharmaceuticals, Laekna, Prothena, Novo Nordisk, Keymed Biosciences, AstraZeneca and f5 Therapeutics:
📊 Ascletis trumpets potential quarterly dosing of GLP-1: An investigational subcutaneous depot formulation of Ascletis’s GLP-1 drug ASC30 …


